AtomVie Global Radiopharma Inc. (AtomVie), a global-leading Contract Development and Manufacturing Organization (CDMO) for the GMP manufacturing and worldwide distribution of radiopharmaceuticals, recently announced the closing of its Tranche 2 Series A financing, reaching over $90M total to complete building its new state-of-the-art GMP manufacturing facility.
Atomvie Global is an OBIO® member.